Anna Helena Jonsson
Concepts (119)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Autoimmune Diseases | 3 | 2025 | 455 | 1.960 |
Why?
| | CD8-Positive T-Lymphocytes | 5 | 2025 | 910 | 1.350 |
Why?
| | Autoimmunity | 2 | 2025 | 904 | 1.170 |
Why?
| | Arthritis, Rheumatoid | 8 | 2025 | 1165 | 1.160 |
Why?
| | Synovial Membrane | 7 | 2024 | 121 | 1.100 |
Why?
| | Granzymes | 2 | 2025 | 50 | 1.060 |
Why?
| | Synovitis | 1 | 2023 | 29 | 0.830 |
Why?
| | T-Lymphocyte Subsets | 1 | 2025 | 416 | 0.790 |
Why?
| | B-Lymphocytes | 4 | 2025 | 855 | 0.480 |
Why?
| | Chromosome Mapping | 2 | 2022 | 505 | 0.290 |
Why?
| | Single-Cell Analysis | 3 | 2024 | 322 | 0.260 |
Why?
| | Adipocytes | 2 | 2024 | 227 | 0.230 |
Why?
| | Adalimumab | 1 | 2024 | 53 | 0.220 |
Why?
| | Diabetes Mellitus, Type 2 | 4 | 2023 | 2516 | 0.220 |
Why?
| | Polymorphism, Single Nucleotide | 3 | 2023 | 2138 | 0.210 |
Why?
| | Th17 Cells | 1 | 2025 | 108 | 0.210 |
Why?
| | Lymphocyte Activation | 2 | 2025 | 1148 | 0.210 |
Why?
| | Quantitative Trait Loci | 2 | 2023 | 362 | 0.210 |
Why?
| | Immunophenotyping | 1 | 2025 | 327 | 0.210 |
Why?
| | Receptors, Glucocorticoid | 1 | 2024 | 138 | 0.200 |
Why?
| | Genetic Variation | 2 | 2018 | 990 | 0.190 |
Why?
| | Fibroblasts | 2 | 2024 | 1002 | 0.190 |
Why?
| | Hydrocortisone | 1 | 2024 | 313 | 0.190 |
Why?
| | CD4-Positive T-Lymphocytes | 2 | 2025 | 1097 | 0.180 |
Why?
| | Body Height | 1 | 2022 | 197 | 0.180 |
Why?
| | Antirheumatic Agents | 1 | 2024 | 292 | 0.170 |
Why?
| | Glucocorticoids | 1 | 2024 | 528 | 0.160 |
Why?
| | Genome-Wide Association Study | 6 | 2023 | 1391 | 0.160 |
Why?
| | Chromatin | 1 | 2024 | 515 | 0.160 |
Why?
| | Receptors, Antigen, T-Cell, alpha-beta | 1 | 2022 | 334 | 0.160 |
Why?
| | Antigens, CD | 1 | 2022 | 537 | 0.160 |
Why?
| | Genes, Mitochondrial | 1 | 2018 | 14 | 0.150 |
Why?
| | Metabolism | 1 | 2018 | 43 | 0.150 |
Why?
| | Humans | 18 | 2025 | 138972 | 0.140 |
Why?
| | Receptors, Antigen, T-Cell | 1 | 2022 | 718 | 0.140 |
Why?
| | DNA, Mitochondrial | 1 | 2018 | 208 | 0.130 |
Why?
| | Transcription Factor 7-Like 2 Protein | 1 | 2017 | 26 | 0.130 |
Why?
| | Gene Expression Regulation | 2 | 2023 | 2591 | 0.120 |
Why?
| | Autoantibodies | 1 | 2023 | 1457 | 0.120 |
Why?
| | Receptor, Melatonin, MT2 | 1 | 2015 | 3 | 0.120 |
Why?
| | Hepatocyte Nuclear Factor 3-beta | 1 | 2015 | 12 | 0.120 |
Why?
| | Insulin | 4 | 2023 | 2447 | 0.120 |
Why?
| | Insulin Resistance | 1 | 2023 | 1222 | 0.110 |
Why?
| | Signal Transduction | 2 | 2024 | 5092 | 0.110 |
Why?
| | Genetic Loci | 1 | 2015 | 281 | 0.110 |
Why?
| | Blood Glucose | 3 | 2023 | 2241 | 0.110 |
Why?
| | Cardiovascular Diseases | 2 | 2022 | 2058 | 0.100 |
Why?
| | Genetic Predisposition to Disease | 2 | 2023 | 2362 | 0.090 |
Why?
| | Mitochondria | 1 | 2018 | 958 | 0.090 |
Why?
| | Biomarkers | 2 | 2022 | 4095 | 0.080 |
Why?
| | Glucose | 3 | 2023 | 1031 | 0.080 |
Why?
| | Heart Failure | 1 | 2022 | 2065 | 0.080 |
Why?
| | Tumor Necrosis Factor-alpha | 2 | 2024 | 1244 | 0.080 |
Why?
| | Transcriptome | 2 | 2024 | 966 | 0.070 |
Why?
| | Longitudinal Studies | 2 | 2024 | 2850 | 0.060 |
Why?
| | Animals | 2 | 2025 | 37243 | 0.060 |
Why?
| | Glucose Tolerance Test | 2 | 2017 | 366 | 0.060 |
Why?
| | 11-beta-Hydroxysteroid Dehydrogenase Type 1 | 1 | 2024 | 9 | 0.060 |
Why?
| | Phenotype | 2 | 2023 | 3143 | 0.060 |
Why?
| | Male | 7 | 2025 | 68250 | 0.050 |
Why?
| | Adipogenesis | 1 | 2024 | 57 | 0.050 |
Why?
| | Lymphocyte Subsets | 1 | 2024 | 88 | 0.050 |
Why?
| | Transcription Factor AP-1 | 1 | 2024 | 88 | 0.050 |
Why?
| | Plasma Cells | 1 | 2024 | 73 | 0.050 |
Why?
| | Arthritis | 1 | 2024 | 101 | 0.050 |
Why?
| | Anti-Citrullinated Protein Antibodies | 1 | 2025 | 114 | 0.050 |
Why?
| | Transforming Growth Factor beta1 | 1 | 2024 | 165 | 0.050 |
Why?
| | T-Box Domain Proteins | 1 | 2024 | 98 | 0.050 |
Why?
| | Case-Control Studies | 2 | 2025 | 3574 | 0.050 |
Why?
| | Interferons | 1 | 2024 | 195 | 0.050 |
Why?
| | Colitis, Ulcerative | 1 | 2024 | 137 | 0.050 |
Why?
| | Asialoglycoprotein Receptor | 1 | 2022 | 6 | 0.050 |
Why?
| | Rheumatoid Factor | 1 | 2024 | 173 | 0.050 |
Why?
| | Antigens, Differentiation, Myelomonocytic | 1 | 2022 | 63 | 0.050 |
Why?
| | Methotrexate | 1 | 2024 | 255 | 0.050 |
Why?
| | Sample Size | 1 | 2022 | 127 | 0.050 |
Why?
| | Complementarity Determining Regions | 1 | 2022 | 51 | 0.050 |
Why?
| | Linkage Disequilibrium | 1 | 2022 | 258 | 0.050 |
Why?
| | Europe | 1 | 2022 | 407 | 0.040 |
Why?
| | Gene Frequency | 1 | 2022 | 501 | 0.040 |
Why?
| | Female | 6 | 2025 | 74016 | 0.040 |
Why?
| | Haplotypes | 1 | 2022 | 497 | 0.040 |
Why?
| | Crohn Disease | 1 | 2024 | 250 | 0.040 |
Why?
| | Genome, Human | 1 | 2022 | 418 | 0.040 |
Why?
| | Cell Lineage | 1 | 2022 | 350 | 0.040 |
Why?
| | Inflammatory Bowel Diseases | 1 | 2024 | 347 | 0.040 |
Why?
| | Aged | 3 | 2025 | 24172 | 0.040 |
Why?
| | Epigenesis, Genetic | 1 | 2024 | 644 | 0.040 |
Why?
| | Waist-Hip Ratio | 1 | 2018 | 40 | 0.040 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2022 | 386 | 0.040 |
Why?
| | Middle Aged | 3 | 2025 | 33782 | 0.040 |
Why?
| | Liver | 2 | 2017 | 1807 | 0.030 |
Why?
| | Transcription, Genetic | 1 | 2024 | 1471 | 0.030 |
Why?
| | Mice, Knockout | 1 | 2024 | 3029 | 0.030 |
Why?
| | Adult | 3 | 2025 | 38393 | 0.030 |
Why?
| | Genotyping Techniques | 1 | 2017 | 74 | 0.030 |
Why?
| | Glucagon-Like Peptide 1 | 1 | 2017 | 131 | 0.030 |
Why?
| | C-Peptide | 1 | 2017 | 163 | 0.030 |
Why?
| | Arginine | 1 | 2017 | 261 | 0.030 |
Why?
| | Peptides | 1 | 2022 | 980 | 0.030 |
Why?
| | Transcription Factors | 1 | 2024 | 1701 | 0.030 |
Why?
| | Cytokines | 1 | 2023 | 2083 | 0.030 |
Why?
| | Molecular Sequence Annotation | 1 | 2015 | 95 | 0.030 |
Why?
| | Chromatin Immunoprecipitation | 1 | 2015 | 136 | 0.030 |
Why?
| | T-Lymphocytes | 1 | 2023 | 1985 | 0.030 |
Why?
| | Linear Models | 1 | 2017 | 855 | 0.030 |
Why?
| | Alleles | 1 | 2017 | 890 | 0.030 |
Why?
| | Mice, Inbred C57BL | 1 | 2024 | 5801 | 0.030 |
Why?
| | Insulin-Secreting Cells | 1 | 2017 | 374 | 0.020 |
Why?
| | Inflammation | 1 | 2023 | 2853 | 0.020 |
Why?
| | Binding Sites | 1 | 2015 | 1317 | 0.020 |
Why?
| | Genotype | 1 | 2017 | 1849 | 0.020 |
Why?
| | Genomics | 1 | 2015 | 797 | 0.020 |
Why?
| | Body Mass Index | 1 | 2018 | 2390 | 0.020 |
Why?
| | Diabetes Mellitus | 1 | 2018 | 1068 | 0.020 |
Why?
| | Islets of Langerhans | 1 | 2015 | 792 | 0.020 |
Why?
| | Cohort Studies | 1 | 2018 | 5744 | 0.020 |
Why?
| | Mice | 1 | 2024 | 17828 | 0.020 |
Why?
| | Risk Factors | 1 | 2017 | 10385 | 0.010 |
Why?
|
|
Jonsson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|